Lesbian, Gay, Bisexual, and Transgender (LGBT) View it Differently Than Non-LGBT: Exposure to Tobacco-related Couponing, E-cigarette Advertisements, and Anti-tobacco Messages on Social and Traditional Media.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
30 03 2019
Historique:
received: 12 06 2017
accepted: 09 03 2018
pubmed: 17 3 2018
medline: 8 1 2020
entrez: 17 3 2018
Statut: ppublish

Résumé

LGBT populations use tobacco at disparately higher rates nationwide, compared to national averages. The tobacco industry has a history targeting LGBT with marketing efforts, likely contributing to this disparity. This study explores whether exposure to tobacco content on traditional and social media is associated with tobacco use among LGBT and non-LGBT. This study reports results from LGBT (N = 1092) and non-LGBT (N = 16430) respondents to a 2013 nationally representative cross-sectional online survey of US adults (N = 17522). Frequency and weighted prevalence were estimated and adjusted logistic regression analyses were conducted. LGBT reported significantly higher rates of past 30-day tobacco media exposure compared to non-LGBT, this effect was strongest among LGBT who were smokers (p < .05). LGBT more frequently reported exposure to, searching for, or sharing messages related to tobacco couponing, e-cigarettes, and anti-tobacco on new or social media (eg, Twitter, Facebook, etc.) than did non-LGBT (p < .05). Non-LGBT reported more exposure from traditional media sources such as television, most notably anti-tobacco messages (p = .0088). LGBT had higher odds of past 30-day use of cigarettes, e-cigarettes, and cigars compared to non-LGBT, adjusting for past 30-day media exposure and covariates (p ≤ .0001). LGBT (particularly LGBT smokers) are more likely to be exposed to and interact with tobacco-related messages on new and social media than their non-LGBT counterparts. Higher levels of tobacco media exposure were significantly associated with higher likelihood of tobacco use. This suggests tobacco control must work toward reaching LGBT across a variety of media platforms, particularly new and social media outlets. This study provides important information about LGBT communities tobacco-related disparities in increased exposure to pro-tobacco messages via social media, where the tobacco industry has moved since the MSA. Further, LGBT when assessed as a single population appear to identify having decreased exposure to anti-tobacco messages via traditional media, where we know a large portion of tobacco control and prevention messages are placed. The study points to the need for targeted and tailored approaches by tobacco control to market to LGBT using on-line resources and tools in order to help reduce LGBT tobacco-related health disparities. Although there have been localized campaigns, only just recently have such LGBT-tailored national campaigns been developed by the CDC, FDA, and Legacy, assessment of the content, effectiveness, and reach of both local and national campaigns will be important next steps.

Sections du résumé

BACKGROUND
LGBT populations use tobacco at disparately higher rates nationwide, compared to national averages. The tobacco industry has a history targeting LGBT with marketing efforts, likely contributing to this disparity. This study explores whether exposure to tobacco content on traditional and social media is associated with tobacco use among LGBT and non-LGBT.
METHODS
This study reports results from LGBT (N = 1092) and non-LGBT (N = 16430) respondents to a 2013 nationally representative cross-sectional online survey of US adults (N = 17522). Frequency and weighted prevalence were estimated and adjusted logistic regression analyses were conducted.
RESULTS
LGBT reported significantly higher rates of past 30-day tobacco media exposure compared to non-LGBT, this effect was strongest among LGBT who were smokers (p < .05). LGBT more frequently reported exposure to, searching for, or sharing messages related to tobacco couponing, e-cigarettes, and anti-tobacco on new or social media (eg, Twitter, Facebook, etc.) than did non-LGBT (p < .05). Non-LGBT reported more exposure from traditional media sources such as television, most notably anti-tobacco messages (p = .0088). LGBT had higher odds of past 30-day use of cigarettes, e-cigarettes, and cigars compared to non-LGBT, adjusting for past 30-day media exposure and covariates (p ≤ .0001).
CONCLUSIONS
LGBT (particularly LGBT smokers) are more likely to be exposed to and interact with tobacco-related messages on new and social media than their non-LGBT counterparts. Higher levels of tobacco media exposure were significantly associated with higher likelihood of tobacco use. This suggests tobacco control must work toward reaching LGBT across a variety of media platforms, particularly new and social media outlets.
IMPLICATIONS
This study provides important information about LGBT communities tobacco-related disparities in increased exposure to pro-tobacco messages via social media, where the tobacco industry has moved since the MSA. Further, LGBT when assessed as a single population appear to identify having decreased exposure to anti-tobacco messages via traditional media, where we know a large portion of tobacco control and prevention messages are placed. The study points to the need for targeted and tailored approaches by tobacco control to market to LGBT using on-line resources and tools in order to help reduce LGBT tobacco-related health disparities. Although there have been localized campaigns, only just recently have such LGBT-tailored national campaigns been developed by the CDC, FDA, and Legacy, assessment of the content, effectiveness, and reach of both local and national campaigns will be important next steps.

Identifiants

pubmed: 29546337
pii: 4931018
doi: 10.1093/ntr/nty049
pmc: PMC6472708
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-522

Subventions

Organisme : NCI NIH HHS
ID : U01 CA154254
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Tob Control. 2015 May;24(3):281-4
pubmed: 24503771
Nicotine Tob Res. 2015 Jan;17(1):2-17
pubmed: 25173775
Health Promot Pract. 2004 Jul;5(3 Suppl):129S-134S
pubmed: 15231106
Int J Environ Res Public Health. 2017 Apr 21;14(4):
pubmed: 28430161
Am J Prev Med. 2016 Feb;50(2):199-209
pubmed: 26410185
Tob Control. 2009 Aug;18(4):275-82
pubmed: 19208668
Tob Induc Dis. 2015 Jun 12;13(1):14
pubmed: 26180523
Am J Public Health. 2012 Nov;102(11):2041-3
pubmed: 22994185
Am J Public Health. 2008 Jun;98(6):996-1003
pubmed: 18445800
Am J Prev Med. 2014 Dec;47(6):823-31
pubmed: 25455123
Am J Public Health. 2007 Aug;97(8):1489-95
pubmed: 17600271
Am J Public Health. 2002 Jul;92(7):1086-95
pubmed: 12084686
Am J Prev Med. 2017 Jul;53(1):e1-e7
pubmed: 28094133
Nicotine Tob Res. 2016 Apr;18(4):496-500
pubmed: 26014455
J LGBT Health Res. 2008;4(1):27-42
pubmed: 19860015
J Health Commun. 2002 Mar-Apr;7(2):113-21
pubmed: 12049420
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD003439
pubmed: 21975739
Tob Control. 2014 Nov;23(e2):e156-8
pubmed: 24277775
Am J Public Health. 2003 Jun;93(6):988-93
pubmed: 12773366
Tob Control. 2008 Dec;17(6):385-90
pubmed: 18723561
Nicotine Tob Res. 2009 Jan;11(1):25-35
pubmed: 19246438
Health Promot Pract. 2014 Nov;15(6):857-66
pubmed: 24801020
J Epidemiol Community Health. 2005 Dec;59(12):1086-91
pubmed: 16286500
Nicotine Tob Res. 2016 Jun;18(6):1494-501
pubmed: 26377512

Auteurs

Kristen Emory (K)

Moores Cancer Center at the University of California, San Diego, Health Sciences Dr., La Jolla, CA.
Graduate School of Public Health, Campanile Drive, San Diego, CA.

Francisco O Buchting (FO)

Horizons Foundation, Suite, San Francisco, CA.

Dennis R Trinidad (DR)

Moores Cancer Center, University of California, San Diego, Health Sciences Dr, La Jolla, CA.

Lisa Vera (L)

VeraCite, Inc., San Diego, CA.

Sherry L Emery (SL)

NORC at the University of Chicago, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH